Timothy A. Springer - Jul 2, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol: RNAC
Transactions as of: Jul 2, 2024
Transactions value $: $47,190,000
Form type: 4
Date filed: 7/5/2024, 04:02 PM
Previous filing: Jun 24, 2024
Next filing: Aug 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$32.7M	+1.64M		$20.00	1.64M	Jul 2, 2024	Direct
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$14.4M	+721K		$20.00	721K	Jul 2, 2024	See Footnote	F1
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$26.1K	+1.31K		$20.00	1.31K	Jul 2, 2024	By wife
holding	RNAC	Common Stock						4.38M	Jul 2, 2024	Direct
holding	RNAC	Common Stock						1.93M	Jul 2, 2024	See Footnote	F1
holding	RNAC	Common Stock						3.49K	Jul 2, 2024	By wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.